支气管炎症促进了对类固醇不敏感的喘小鼠的Th17炎症
Yun Lin1,2,3, Jianhua Yin1,2,3, Xia Yang4
1Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital of Guilin Medical University, Guilin, China.
Innate immunity
|August 28, 2025
概括
支气管细胞亡是一种细胞死亡形式,在类固醇不敏感的喘中促进Th17炎症. 在小鼠模型中,用MCC950抑制NLRP3 (NOD,LRR和pyrin域含蛋白3) 降低了这种炎症.
科学领域:
- 免疫学
- 细胞生物学
- 呼吸系统医学
背景情况:
- 类固醇不敏感的喘涉及支气管细胞亡和IL-17.
- 在这种情况下,热和Th17之间的相互作用需要进一步阐明.
研究的目的:
- 在类固醇不敏感的喘中研究支气管细胞炎症与Th17介导的呼吸道炎症之间的关系.
- 在这种喘模型中探索NLRP3抑制的治疗潜力.
主要方法:
- 使用多二酸盐 (TDI) 诱导了对类固醇不敏感的小鼠喘模型.
- 通过传导电子显微镜评估了支气管上皮细胞炎症.
- 使用西部抹杀,流细胞计量和免疫组织化学分析了蛋白质和细胞亡标记物 (Caspase-1,GSDMD,HMGB1),Th17 (IL-17A,IL-17F,p-STAT3) 和细胞计数.
- 用于评估NLRP3抑制剂MCC950的作用.
主要成果:
- 在TDI诱导的对类固醇不敏感的喘中,小鼠表现出确定的支气管上皮细胞亡.
- 在肺组织中观察到与热亡标记物 (Caspase- 1 p20, cleaved- GSDMD,HMGB1) 和与Th17相关的因子 (p- STAT3,IL- 17A,IL- 17F) 的蛋白质表达增加.
- 治疗MCC950显著减弱了热和Th17炎症标志物.
- 呼吸道IL-17A+和p- STAT3+细胞的增加被MCC950降低.
结论:
- 支气管上皮细胞炎症有助于对类固醇不敏感的喘的 Th17 炎症.
- 通过使用MCC950向NLRP3炎症酶,通过减少热和Th17反应,显示出治疗潜力.
- 这项研究增强了对类固醇不敏感喘病因的先天性和获得性免疫相互作用的理解.
相关概念视频
01:20Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
451
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
451
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:19Antiasthma Drugs: Leukotriene Modifiers
461
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
461